Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Treasury Shares (2020 - 2025)

Journey Medical (DERM) has disclosed Treasury Shares for 6 consecutive years, with $1.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares fell 23.63% year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Sep 2025, down 23.63%, and an annual FY2024 reading of $2.3 million, up 79.04% over the prior year.
  • Treasury Shares was $1.9 million for Q3 2025 at Journey Medical, down from $2.4 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.7 million in Q2 2024 and bottomed at $708524.0 in Q3 2021.
  • Average Treasury Shares over 5 years is $1.8 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Treasury Shares skyrocketed 238.96% in 2022, then tumbled 43.13% in 2023.
  • Year by year, Treasury Shares stood at $715030.0 in 2021, then soared by 216.22% to $2.3 million in 2022, then crashed by 42.2% to $1.3 million in 2023, then soared by 79.04% to $2.3 million in 2024, then decreased by 18.91% to $1.9 million in 2025.
  • Business Quant data shows Treasury Shares for DERM at $1.9 million in Q3 2025, $2.4 million in Q2 2025, and $2.3 million in Q1 2025.